メタゲノムの世界市場：用途別、技術別、製品別、ユーザー別予測 - エグゼクティブコンサルタントガイド付き（2024年～2028年）

健康と病気における遺伝学の役割は、今まさに理解されつつあります。この新しい知識は、コストの低下と相まって、新しいタイプの遺伝子検査に拍車をかけています。メタゲノム検査は、サンプル中のすべての遺伝物質を調べるものです。その過程で、感染症、がん、抗菌薬耐性、患者のゲノムについて知ることができるという、まったく新しいアプローチです。人間の医療から廃水研究まで、この新しいアプローチは驚くべき答えを生み出しています。そしてその過程で、新しい種類の生物や病原体を発見しています。すでにいくつかの小さな医学的奇跡が達成されています。

当レポートは、世界の遺伝子検査市場について調査し、市場の概要とともに、用途別、技術別、製品別、ユーザー別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

第3章 市場概要

• 市場参入組織
  • 学術研究機関
  • 診断試験開発者
  • 計装サプライヤー
  • 薬品・試薬メーカー
  • 病理サプライヤー
  • 独立系臨床検査室
  • 公共の国立/地域研究所
  • 病院検査室
  • 臨床検査室
  • 監査機関
  • 認証機関
• メタゲノミクスの応用
  • 臨床メタゲノミクス
  • 診断用途
  • 多重症候群検査とメタゲノム検査
  • 抗菌耐性
  • マイクロバイオームの管理
  • 公衆衛生上の使用
• 臨床業界の構造

第4章 市場動向

• 成長促進要因
• 成長抑制要因
• 計測、自動化、診断の動向

第5章 メタゲノミクスの最近の発展

第6章 主要企業の概要

• Arc Bio
• BaseClear
• BGI Genomics Co. Ltd.
• Biome Makers
• bioMérieux Diagnostics
• Bio-Rad Laboratories, Inc.
• CosmosID
• Element Biosciences
• Fusion Genomics.
• Helix OpCo
• Illumina
• Institute for Metagenomics
• Karius
• Metabiomics Corp.
• Metagenomi
• MetaSUB International Consortium
• Microbiome Insights
• MicroGenDx
• Molecular Stethoscope
• Norgen Biotek Corp.
• Noscendo
• Novogene Bioinformatics Technology Co., Ltd.
• One Codex
• OraSure Technologies
• Oxford Nanopore Technologies
• Pacific Biosciences
• PathoQuest S.A.
• Perkin Elmer
• Promega
• Qiagen
• Second Genome
• Siemens Healthineers
• Sysmex
• Takara Bio
• Ultima Genomics
• Zymo Research Corp.

第7章 世界市場規模

• 国別の世界市場
• 用途別の世界市場
• 技術別の世界市場
• 製品別の世界市場
• ユーザー別の世界市場

第8章 用途別の市場規模

• 臨床市場
• マイクロバイオーム市場
• 農業市場
• 産業用およびその他

第9章 技術別の市場規模

• 16srRNA市場
• ショットガン市場
• WGS市場
• その他

第10章 製品別の市場規模

• 機器市場
• 試薬・キット市場
• ソフトウェア市場
• サービス市場

第11章 ユーザー別の市場規模

• 学術市場
• 臨床市場
• 医薬品市場
• その他

第12章 付録

Table of Tables

• Table 1: The Base Pairs
• Table 2: Market Players by Type
• Table 3: The Different Applications of Metagenomic Testing
• Table 4: Factors Driving Growth
• Table 5: Four Factors Limiting Growth
• Table 6: Seven Key Diagnostic Laboratory Technology Trends
• Table 7: Global Market by Country
• Table 8: Global Market by Application
• Table 9: Global Market by Technology
• Table 10: Global Market by Product
• Table 11: Global Market by User
• Table 12: Clinical Segment by Country
• Table 13: Microbiome Segment by Country
• Table 14: Agriculture Segment by Country
• Table 15: Industrial & Other Segment by Country
• Table 16: 16srRNA Segment by Country
• Table 17: Shotgun Segment by Country
• Table 18: WGS Segment by Country
• Table 19: Other Technology Segment by Country
• Table 20: Instruments Segment by Country
• Table 21: Reagents and Kits Segment by Country
• Table 22: Software Segment by Country
• Table 23: Services Segment by Country
• Table 24: Academic Segment by Country
• Table 25: Clinical Segment by Country
• Table 26: Pharmaceutical Segment by Country
• Table 27: Other User Segment by Country
• Table 28: Clinical Lab Fee Schedule
• Table 29: The Most Common Assays
• Table 30: Largest Revenue Assays

Table of Figures

• Figure 1: Global Health Care Spending
• Figure 2: The Lab Test Pie
• Figure 3: DNA Strands and Chromosomes
• Figure 4: Karyogram of Human Chromosomes
• Figure 5: Size of Various Genomes
• Figure 6: The Road to Diagnostics
• Figure 7: The New Diagnostics
• Figure 8: The Changing Age of the World Population
• Figure 9: Health Care Consumption by Age
• Figure 10: Cancer Incidence - Age at Diagnosis
• Figure 11: Centralized vs. Decentralized Laboratory Service
• Figure 12: A Highly Multiplexed Syndromic Testing Unit
• Figure 13: The Real Cost to Sequence the Human Genome
• Figure 14: The Codevelopment Process
• Figure 15: Comparing MDx Diagnostic and Traditional Testing
• Figure 16: Country Market Shares
• Figure 17: Application Share by Year
• Figure 18: Application Segment Growth Rates
• Figure 19: Segment Share Shifts
• Figure 20: Application Segment Share Base Year
• Figure 21: Application Segment Share Final Year
• Figure 22: Technology Share by Year
• Figure 23: Technology Segment Growth Rates
• Figure 24: Technology Segment Share Shifts
• Figure 25: Technology Segment Share Base Year
• Figure 26: Technology Segment Share Final Year
• Figure 27: Product Share by Year
• Figure 28: Product Segment Growth Rates
• Figure 29: Product Segment Share Shifts
• Figure 30: Product Segment Share Base Year
• Figure 31: Product Segment Share Final Year
• Figure 32: User Share by Year
• Figure 33: User Segment Growth Rates
• Figure 34: User Segment Share Shifts
• Figure 35: User Segment Share Base Year
• Figure 36: User Segment Share Final Year
• Figure 37: Clinical vs. Total Market Growth
• Figure 38: Microbiome vs. Total Market Growth
• Figure 39: Agriculture vs. Total Market Growth
• Figure 40: Industrial & Other vs. Total Market Growth
• Figure 41: 16srRNA vs. Total Market Growth
• Figure 42: Shotgun vs. Total Market Growth
• Figure 43: WGS vs. Total Market Growth
• Figure 44: Other Technology vs. Total Market Growth
• Figure 45: Instrument vs. Total Market Growth
• Figure 46: Reagents and Kits vs. Total Market Growth
• Figure 47: Software vs. Total Market Growth
• Figure 48: Services vs. Total Market Growth
• Figure 49: Academic vs. Total Market Growth
• Figure 50: Clinical vs. Total Market Growth
• Figure 51: Pharmaceutical vs. Total Market Growth
• Figure 52: Other User Growth

OVERVIEW:

Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. Metagenomic Testing looks at all the genetic material in a sample. In the process it learns about infection, cancer, antimicrobial resistance, and the patient genome. It's a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. And finding new kinds of organisms and pathogens in the process. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.

Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

• B.Sc. (Chemistry) University of BC
• M.B.A. (Finance and Policy) University of BC
• Market Research Seminar - Burke Institute
• Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. What is Metagenomics?
• 2.2. Market Definition
  • 2.2.1. Revenue Market Size.
  • 2.2.2. Clinical
  • 2.2.3. Microbiome
  • 2.2.4. Agricultural
  • 2.2.5. Environmental & Other
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics
• 2.5. Chromosomes, Genes and Epigenetics
  • 2.5.1. Chromosomes
  • 2.5.2. Genes
  • 2.5.3. Epigenetics

3. Market Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Metagenomics Applications
  • 3.2.1. Clinical Metagenomics
  • 3.2.2. Diagnostic Use
  • 3.2.3. Syndromic Multiplex vs. Metagenomic Testing
  • 3.2.4. Antimicrobial Resistance
  • 3.2.5. Managing the Microbiome
  • 3.2.6. Public Health Use
• 3.3. Clinical Industry Structure
  • 3.3.1. Hospital's Testing Share
  • 3.3.2. Economies of Scale
  • 3.3.3. Hospital vs. Central Lab
  • 3.3.4. Physician Office Lab's
  • 3.3.5. Physician's and POCT

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. A New Approach to Diagnostics
  • 4.1.2. The Aging Effect
  • 4.1.3. The Known and the Unknown
  • 4.1.4. A Research Bonanza
• 4.2. Factors Limiting Growth
  • 4.2.1. Increased Competition Lowers Price
  • 4.2.2. Lower Costs
  • 4.2.3. Testing usage analysis curtailing growth
  • 4.2.4. Wellness has a downside
• 4.3. Instrumentation, Automation and Diagnostic Trends
  • 4.3.1. Traditional Automation and Centralization
  • 4.3.2. The New Automation, Decentralization and Point of Care
  • 4.3.3. Instruments Key to Market Share
  • 4.3.4. Bioinformatics Plays a Role
  • 4.3.5. PCR Takes Command
  • 4.3.6. Next Generation Sequencing Fuels a Revolution
  • 4.3.7. NGS Impact on Pricing
  • 4.3.8. Whole Genome Sequencing, A Brave New World
  • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10. Shifting Role of Diagnostics

5. Metagenomics Recent Developments

• 5.1. Recent Developments
  • 5.1.1. Importance of This Section
  • 5.1.2. How to Use This Section
• 5.2. UK and U.S. Use Metagenomics for Biothreat Assessment
• 5.3. Phase Genomics Metagenomics Innovation Award
• 5.4. New Method for Human Gut Assessment
• 5.5. Metagenomic sequencing Used for Pneumonia Care
• 5.6. Sepsis Study Shows Metagenomic Clinical Value
• 5.7. Delve Bio to Develop Metagenomic Sequencing Dx
• 5.8. Metagenomics Could be a Game-changer
• 5.9. Model Predicts Millions of Metagenomic Proteins
• 5.10. Microbiome Analysis May Yield False Results
• 5.11. Gut microbiome at center of Parkinson's disease
• 5.12. MicroGenDx, Evvy Partner for Metagenomic Test
• 5.13. Diagnostic accuracy of metagenomic NGS
• 5.14. Metagenomics implicates the gut microbiome
• 5.15. Charities Award $2M for Metagenomic Pathogen Research
• 5.16. Cost-effective metagenomic HiFi sequencing
• 5.17. Microbiome Links Uncovered
• 5.18. Metagenomi Named an Endpoints 11 Winner
• 5.19. Biotia Raises $8M in Series A Financing

6. Profiles of Key Companies

• 6.1. Arc Bio
• 6.2. BaseClear
• 6.3. BGI Genomics Co. Ltd.
• 6.4. Biome Makers
• 6.5. bioMérieux Diagnostics
• 6.6. Bio-Rad Laboratories, Inc.
• 6.7. CosmosID
• 6.8. Element Biosciences
• 6.9. Fusion Genomics.
• 6.10. Helix OpCo
• 6.11. Illumina
• 6.12. Institute for Metagenomics
• 6.13. Karius
• 6.14. Metabiomics Corp.
• 6.15. Metagenomi
• 6.16. MetaSUB International Consortium
• 6.17. Microbiome Insights
• 6.18. MicroGenDx
• 6.19. Molecular Stethoscope
• 6.20. Norgen Biotek Corp.
• 6.21. Noscendo
• 6.22. Novogene Bioinformatics Technology Co., Ltd.
• 6.23. One Codex
• 6.24. OraSure Technologies
• 6.25. Oxford Nanopore Technologies
• 6.26. Pacific Biosciences
• 6.27. PathoQuest S.A.
• 6.28. Perkin Elmer
• 6.29. Promega
• 6.30. Qiagen
• 6.31. Second Genome
• 6.32. Siemens Healthineers
• 6.33. Sysmex
• 6.34. Takara Bio
• 6.35. Ultima Genomics
• 6.36. Zymo Research Corp.

7. Global Market Size

• 7.1. Global Market by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Country Market Shares
• 7.2. Global Market by Application
  • 7.2.1. Table - Global Market by Application
  • 7.2.2. Chart - Application Share by Year
  • 7.2.3. Chart - Application Segment Growth Rates
  • 7.2.4. Chart - Application Segment Share Shifts
  • 7.2.5. Chart - Application Segment Share Base Year
  • 7.2.6. Chart - Application Segment Share Final Year
• 7.3. Global Market by Technology
  • 7.3.1. Table - Global Market by Technology
  • 7.3.2. Chart - Technology Share by Year
  • 7.3.3. Chart - Technology Segment Growth Rates
  • 7.3.4. Chart - Technology Segment Share Shifts
  • 7.3.5. Chart - Technology Segment Share Base Year
  • 7.3.6. Chart - Technology Segment Share Final Year
• 7.4. Global Market by Product
  • 7.4.1. Table - Global Market by Product
  • 7.4.2. Chart - Product Share by Year
  • 7.4.3. Chart - Product Segment Growth Rates
  • 7.4.4. Chart - Product Segment Share Shifts
  • 7.4.5. Chart - Product Segment Share Base Year
  • 7.4.6. Chart - Product Segment Share Final Year
• 7.5. Global Market by User
  • 7.5.1. Table - Global Market by User
  • 7.5.2. Chart - User Share by Year
  • 7.5.3. Chart - User Segment Growth Rates
  • 7.5.4. Chart - User Segment Share Shifts
  • 7.5.5. Chart - User Segment Share Base Year
  • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

• 8.1. Clinical Market
  • 8.1.1. Table Clinical - by Country
  • 8.1.2. Chart - Clinical Growth
• 8.2. Microbiome Market
  • 8.2.1. Table Microbiome - by Country
  • 8.2.2. Chart - Microbiome Growth
• 8.3. Agriculture Market
  • 8.3.1. Table Agriculture - by Country
  • 8.3.2. Chart - Agriculture Growth
• 8.4. Industrial & Other Market
  • 8.4.1. Table Industrial & Other - by Country
  • 8.4.2. Chart - Industrial & Other Growth

9. Market Sizes by Technology

• 9.1. 16srRNA Market
  • 9.1.1. Table 16srRNA - by Country
  • 9.1.2. Chart - 16srRNA Growth
• 9.2. Shotgun Market
  • 9.2.1. Table Shotgun - by Country
  • 9.2.2. Chart - Shotgun Growth
• 9.3. WGS Market
  • 9.3.1. Table WGS - by Country
  • 9.3.2. WGS - Growth
• 9.4. Other Technology Market
  • 9.4.1. Table Other Technology - by Country
  • 9.4.2. Chart - Other Technology Growth

10. Market Sizes by Product

• 10.1. Instruments Market
  • 10.1.1. Table Instruments - by Country
  • 10.1.2. Chart - Instrument Growth
• 10.2. Reagents and Kits Market
  • 10.2.1. Table Reagents and Kits - by Country
  • 10.2.2. Chart - Reagents and Kits Growth
• 10.3. Software Market
  • 10.3.1. Table Software - by Country
  • 10.3.2. Software Growth
• 10.4. Services Market
  • 10.4.1. Table Services - by Country
  • 10.4.2. Chart - Services Growth

11. Market Sizes by User

• 11.1. Academic Market
  • 11.1.1. Table Academic - by Country
  • 11.1.2. Chart - Academic Growth
• 11.2. Clinical Market
  • 11.2.1. Table Clinical - by Country
  • 11.2.2. Chart - Clinical Growth
• 11.3. Pharmaceutical Market
  • 11.3.1. Table Pharmaceutical - by Country
  • 11.3.2. Pharmaceutical - Predictive Growth
• 11.4. Other User Market
  • 11.4.1. Table Other User - by Country
  • 11.4.2. Chart - Other User Growth

12. Appendices

• 12.1. United States Medicare System: Laboratory Fees Schedule
• 12.2. The Most Used IVD Assays
• 12.3. The Highest Grossing Assays